Stay updated on Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no study details or navigation were affected.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding-lapse notice (and its prior Revision: v3.4.1). No core study content, eligibility criteria, or results were modified.
    Difference
    0.3%
    Check dated 2026-02-11T11:44:25.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding notice detailing operational status of the NIH Clinical Center and updated the site to revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:28:13.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated QC-related metadata (Revision: v3.4.0; Last Update Submitted that Met QC Criteria). Removed or renamed the previous QC label and version (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-28T06:23:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T03:12:51.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A consolidated 'Locations' section lists all participating sites by state, replacing the previous per-state location sections. The HHS Vulnerability Disclosure link was removed and the page updated to Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T21:56:39.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.